AcroMetrix™ Multi-Analyte ctDNA Plasma Control A - E (RUO)

Validate and assess run-to-run assay variation of ctDNA somatic mutation panels. Intended for use with next generation sequencing (NGS), qualitative/quantitative PCR assays designed to identify somatic mutations in DNA from liquid biopsy samples. For research use only.

Normal human plasma matrix:

• Exceptional DNA recovery for confident verification of extraction procedures

5 variant allele frequencies

• Accurate identification of 13 variants (including SNV, INDEL, and CNV variant types)

Broad range of cancer types

• Breast, colon, lung, ovaries, pancreas, skin, thyroid, and more

Verified for research use

• Validated on droplet digital PCR and amplicon-based NGS platforms

FAQs

• Why Do We Need Quality Controls for Oncology Assays?
• What is the Role of Circulating Tumor DNA Reference Materials in the Field of Liquid Biopsy?
• Where can I access more of AcroMetrix RUO solutions?
• Is there an e-commerce portal for web-orderable products?